Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?

Journal of Pediatrics

Volumn 141, Issue 5, 2002, Pages 606-610

  Lanes, Roberto ^a   Jakubowicz, Salomon ^a  

^a Hospital de Clinicas Caracas   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; GROWTH HORMONE; LEVODOPA; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

AGE; ARTICLE; BODY HEIGHT; BONE AGE; CLINICAL ARTICLE; DOSE CALCULATION; DOSE RESPONSE; DRUG SAFETY; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HUMAN; HUMAN TISSUE; MALE; MEASUREMENT; PATIENT COMPLIANCE; PREPUBERTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

EID: 0036844232     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.127662     Document Type: Article

References (18)

1. de Boer H, Block GJ, Poo-Snijders C, Stuurman L, Baxter RC, van der Veen E. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J Clin Endocrinol Metab 1996;81:1371-7.
2. Johansson G, Rosen T, Bengtsson BA. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clin Endocrinol 1997;47:571-81.
3. Drake WM, Coyte D, Camacho-Hubner C, Jivanji NM, Kaltsas G, Wood DF, et al. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 1998;83:3913-9.
4. Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP. Body composition and quality of llfe in adults with growth hormone deficiency: Effects of low-dose growth hormone replacement. Clin Endocrinol 2001;54: 709-17.
5. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, et al. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 1998;83:107-16.
6. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309-17.
7. Lanes R, Recker B, Fort P, Lifshitz F. Low-dose oral clonidine: A simple and reliable growth hormone screening test for children. Arch Pediatr Adolesc Med 1985;139:87-9.
8. Donnadieu M, Evain-Brion D, Tonon MC, Vaudry H, Job JC. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children. J Clin Endocrinol Metab 1985;60:1132-4.
9. Mendez-Castellano H, Lopez-Contreras M, Landaeta-Jimenez M, Gonzalez-Tineo A, Pereira I. Estudio transversal de Caracas. Arch Pediatr Puericult 1986;49:111-55.
10. Shim M, Cohen P. IGFs and human cancer: Implications regarding the risk of growth hormone therapy. Horm Res 1999;51:42-51.
11. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 1998;351:1393-6.
12. Rappaport R, Mugnier E, Limoni C, Crosnier H, Czernichow P, Leger J, et al. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. J Clin Endocrinol Metab 1997;82:452-6.
13. Blethen SL, Baptista J, Kuntze J, Foley T, LaFranchi S, Johanson AJ. The Genentech Growth Study Group. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. J Clin Endocrinol Metab 1997;82:418-20.
14. Wettertau L, Cohen P. Role of insulin-like growth factor monitoring in optimizing growth hormone therapy. J Pediatr Endocrinol Metab 2000;13: 1371-6.
15. Tillmann V, Patel L, Gill MS, Whatmore AJ, Price DA, Kibirige MS, et al. Monitoring serum insulin-like growth factor-1 (IGF-1), IGF binding protein-3 (IGFBP-3), IGF-1/IGFBP-3 molar ratio, and leptin during growth hormone treatment for disordered growth. Clin Endocrinol 2000; 53:329-36.
16. Rikken B, van Doorn J, Ringeling A, Van den Brande JL, Massa G, Wit JM. Plasma levels of insulln-like growth factor (IFGF)-1, IGF-2, and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res 1998;50:166-76.
17. Rosenfeld RG, Kemp SF, Hintz RL. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. J Clin Endocrinol Metab 1981;53:611-7.
18. Dean HJ, Kellett RM, Bala RM, Guyda HJ, Bhaumick B, Posner BI, et al. The effect of growth hormone treatment on somatomedin levels in growth hormone-deficient children. J Clin Endocrinol Metab 1982;55:1167-72.